Revive Therapeutics (CSE:RVV) has filed its pre-IND meeting request with the U.S. FDA for Bucillamine in the treatment of COVID-19.
Revive Therapeutics (CSE:RVV), a life sciences company, has learnt that buy recommendations and letters are being circulated in Germany.
Relevium Technologies Inc. (TSXV:RLV, OTCQB:RLLVF, Frankfurt:6BX) announce it has sourced and will begin commercializing a line of Bioganix® hand sanitizers.
Algernon Pharmaceuticals Inc. (CSE:AGN) is pleased to announce that the protocol for a planned physician initiated phase 2 clinical study...
Data Accepted for Presentation at the American College of Cardiology Annual Meeting
RAMM Pharma announces that it will not be filing its interim financial statements for the quarter ended January 31, 2020.
Algernon has submitted for ethics approval in Australia for its planned Phase 2 study of its re-purposed drug NP-120 for IPF...